Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Acute Myeloid Leukemia (AML) Hospitalizations: Racial Disparity in Outcomes of Patients with Comorbidities

Sara Taveras Alam, Deepa Dongarwar, Elyse Lopez, Sarvari Venkata Yellapragada, Gustavo Rivero, Courtney Nicole Miller-Chism, Martha P. Mims, Quillan Huang, Hamisu Salihu

Blood (2021) 138 (Supplement 1): 4135.

https://doi.org/10.1182/blood-2021-153029

Published: 2021

Journal Articles

Epigenetic Silencing of MYC By Proteasome Inhibitors

Andre Catic, Laure Maneix, Polina Iakova, Ragini Mistry, Fabio Stossi, Sarvari Venkata Yellapragada, Premal D. Lulla

Blood (2021) 138 (Supplement 1): 2212.

https://doi.org/10.1182/blood-2021-151315

Published: 2021

Journal Articles

Weight Loss Predicts Inferior Outcome in Polycythemia Vera Patients

Albert Jang, MD, Hussein Hamad, MD, Sarvari Venkata Yellapragada, MD, Iberia R. Sosa, MD PhD, Gustavo A. Rivero, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-134801

Published: 2020

Journal Articles

Elderly Hemopoietic and Inflammatory Signature for Life-Threatening COVID-19 Infection

Jesus Romero, Jorge Mazzini, MD, Sarvari Venkata Yellapragada, MD, Iberia R. Sosa, MD PhD, Gustavo A. Rivero, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-141466

Published: 2020

Journal Articles

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Cenk Yildirim, MS, Aimaz Afrough, MD, Adanma Anji Ayanambakkam Attanathi, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 1806.

https://doi.org/10.1182/blood-2019-132227

Published: 2019

Journal Articles

With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA Study

Anusha Munjuluri, MSc, Nathanael Fillmore, PhD, Diana Cirstea, MD, Hassan Yameen, MD, Sarvari Venkata Yellapragada, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 4388.

https://doi.org/10.1182/blood-2019-131247

Published: 2019

Journal Articles

Evaluating Mean Corpuscular Volume As Predictor for Erythropoiesis Stimulating Agent Response in Elderly Patients Diagnosed with Myelodysplasia

Joshua P Muniz, MD, Sarvari Venkata Yellapragada, MD, Gustavo A. Rivero, MD

Blood (2019) 134 (Supplement_1): 5420.

https://doi.org/10.1182/blood-2019-131458

Published: 2019

Journal Articles

Protein Phase Separation in Hematopoietic Stem Cell Aging

Laure Maneix, PhD, Polina Iakova, M.S., Shannon Moree, B.A., Melanie Sweeney, B.A., Nagaishwarya Moka, MD, Sarvari Venkata Yellapragada, MD, Andre Catic, MD PhD

Blood (2019) 134 (Supplement_1): 5003.

https://doi.org/10.1182/blood-2019-124092

Published: 2019

Journal Articles

Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification

Aimaz Afrough, MD, Rafee Talukder, MD, Sarvari Venkata Yellapragada, MD, Purnima Sravanti Teegavarapu, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2019) 134 (Supplement_1): 2678.

https://doi.org/10.1182/blood-2019-129183

Published: 2019

Journal Articles

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Mehmet Kemal Samur, PhD, Gustavo A. Rivero, MD, Saiju Pyarajan, PhD, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 3191.

https://doi.org/10.1182/blood-2018-99-119490

Published: 2018

Journal Articles

Predictive Factors for Complete Remission and Survival in AML Patients Failing to Achieve Adequate Bone Marrow Day 14 Blast Eradication

Rafee Talukder, MD, Sarvari Venkata Yellapragada, MD, Hussein Hamad, MD, Gustavo A. Rivero, MD

Blood (2018) 132 (Supplement 1): 1464.

https://doi.org/10.1182/blood-2018-99-115830

Published: 2018

Journal Articles

Vitamin D Deficiency Predicts for Poor Overall Survival in Caucasian but Not African American Patients with Multiple Myeloma

Sarvari Venkata Yellapragada, MD, Anna Frolov, M.S., M.A, Nathanael Fillmore, PhD, Pallavi Dev, Sumaira Shafi, MD, Ifeorah Chizoba, MPH, Do Nhan, MD, Do T Nhan, MD, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 1890.

https://doi.org/10.1182/blood-2018-99-117268

Published: 2018

Journal Articles

Dynamic Regulation of Histone Acetylation By Nuclear Proteolysis Controls Cell Cycle Gene Expression and Chromosome Integrity in Multiple Myeloma

Laure Maneix, PhD, Polina Iakova, M.S., Shannon Moree, B.A., Luke Fletcher, MD, Premal Lulla, MBBS, Sarvari Venkata Yellapragada, M.B.B.S., MD, Andre Catic, MD, PhD

Blood (2017) 130 (Supplement 1): 1753.

https://doi.org/10.1182/blood.V130.Suppl_1.1753.1753

Published: 2017

Journal Articles

Traceable Red Cell Distribution Width Modifications Are Observed Prior to MDS Diagnosis and Primarily Associated with Cardiovascular Organ Dysfunction

Claudia Rodriguez, MD,, Alcedo Pedro, Sarvari Venkata Yellapragada, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2016) 128 (22): 5537.

https://doi.org/10.1182/blood.V128.22.5537.5537

Published: 2016

Journal Articles

Survival Improvement in Myelodysplastic Syndrome with Refractory Anemia after Treatment with Selective-Serotonin-Reuptake-Inhibitors

Gabriela Sanchez, MD, Ang Li, MD, Sarvari Venkata Yellapragada, MD, Martha P. Mims, Anna Frolov, Effie Rahman, Gustavo A. Rivero, MD

Blood (2014) 124 (21): 5621.

https://doi.org/10.1182/blood.V124.21.5621.5621

Published: 2014

Journal Articles

Cigarette Smoking Is Associated with Adverse Outcome in Low Risk MDS Patients

Effie Rahman, Sarvari Venkata Yellapragada, Martha P. Mims, Kirtan Nautiyal, MD, Manuel Molina, MD, Gustavo A. Rivero, MD

Blood (2014) 124 (21): 5628.

https://doi.org/10.1182/blood.V124.21.5628.5628

Published: 2014

Journal Articles

The Impact Of The Establishment Of a Hematology Telemedicine Consult Service In a Referral Center On Patients’ Travel Distance, Travel Cost and Satisfaction Scores

Sarvari Venkata Yellapragada, MD, Jesus Hermosillo-Rodriguez, MD, Yvonne Sada, MD, Annette Walder, M.S., Kathy Sam, MD, Alka Mulchandani, MD, Teresa G Hayes, M.D., Davila A Jessica, Ph.D.

Blood (2013) 122 (21): 5601.

https://doi.org/10.1182/blood.V122.21.5601.5601

Published: 2013

Journal Articles

Intrinsic Biological Variability In High-Risk-Myelodysplastic Syndrome Impacts Overall Survival (OS) In Patients Experiencing Cytogenetic Evolution Treated With Azanucleosides

Ruben Hernandez Perez, Ang Li, Sarvari Venkata Yellapragada, MBBS, MD, Matthew Zheng, Maria Otazo, Martha Mims, MD, Gustavo A. Rivero, MD

Blood (2013) 122 (21): 1537.

https://doi.org/10.1182/blood.V122.21.1537.1537

Published: 2013

Journal Articles

Time Dependent Platelet Attrition Identifies Biological Subgroup In Intermediate But Not Low-Risk Myelodysplastic Syndrome (MDS) Revised-IPSS (R-IPSS) Exhibiting Distinct Overall Survival

Gustavo A. Rivero, MD, Maria Otazo, Sarvari Venkata Yellapragada, MD, Ang Li, Matthew Zheng, Ruben Hernandez Perez, Martha Mims, MD

Blood (2013) 122 (21): 5233.

https://doi.org/10.1182/blood.V122.21.5233.5233

Published: 2013

Journal Articles

Impact Of Revised-International Prognostic Scoring System (R-IPSS) Cytogenetic-Risk Stratification In Myelodysplastic Syndrome

Maria Otazo, Sarvari Venkata Yellapragada, MBBS, MD, Matthew Zheng, Ang Li, Ruben Hernandez Perez, Gustavo A. Rivero, MD

Blood (2013) 122 (21): 5234.

https://doi.org/10.1182/blood.V122.21.5234.5234

Published: 2013

NARROW

Acute Myeloid Leukemia (AML) Hospitalizations: Racial Disparity in Outcomes of Patients with Comorbidities

Epigenetic Silencing of MYC By Proteasome Inhibitors

Weight Loss Predicts Inferior Outcome in Polycythemia Vera Patients

Elderly Hemopoietic and Inflammatory Signature for Life-Threatening COVID-19 Infection

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA Study

Evaluating Mean Corpuscular Volume As Predictor for Erythropoiesis Stimulating Agent Response in Elderly Patients Diagnosed with Myelodysplasia

Protein Phase Separation in Hematopoietic Stem Cell Aging

Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

Predictive Factors for Complete Remission and Survival in AML Patients Failing to Achieve Adequate Bone Marrow Day 14 Blast Eradication

Vitamin D Deficiency Predicts for Poor Overall Survival in Caucasian but Not African American Patients with Multiple Myeloma

Dynamic Regulation of Histone Acetylation By Nuclear Proteolysis Controls Cell Cycle Gene Expression and Chromosome Integrity in Multiple Myeloma

Traceable Red Cell Distribution Width Modifications Are Observed Prior to MDS Diagnosis and Primarily Associated with Cardiovascular Organ Dysfunction

Survival Improvement in Myelodysplastic Syndrome with Refractory Anemia after Treatment with Selective-Serotonin-Reuptake-Inhibitors

Cigarette Smoking Is Associated with Adverse Outcome in Low Risk MDS Patients

The Impact Of The Establishment Of a Hematology Telemedicine Consult Service In a Referral Center On Patients’ Travel Distance, Travel Cost and Satisfaction Scores

Intrinsic Biological Variability In High-Risk-Myelodysplastic Syndrome Impacts Overall Survival (OS) In Patients Experiencing Cytogenetic Evolution Treated With Azanucleosides

Time Dependent Platelet Attrition Identifies Biological Subgroup In Intermediate But Not Low-Risk Myelodysplastic Syndrome (MDS) Revised-IPSS (R-IPSS) Exhibiting Distinct Overall Survival

Impact Of Revised-International Prognostic Scoring System (R-IPSS) Cytogenetic-Risk Stratification In Myelodysplastic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only